| Apr 30, 2018 |
May 2, 2018 |
PALVELLA THERAPEUTICS, INC.
|
10% Owner |
Sell |
16.3
|
-1,000,000
|
-18.02%
|
✗
|
$6.4M |
| Mar 2, 2018 |
Mar 6, 2018 |
GLAUKOS Corp
|
Director |
Sell |
15.0
|
-836,500
|
-36.45%
|
✗
|
$26.8M |
| Feb 13, 2018 |
Feb 15, 2018 |
PALVELLA THERAPEUTICS, INC.
|
10% Owner |
Sell |
47.5
|
-7,897
|
-0.14%
|
✗
|
$70.9K |
| Jan 3, 2018 |
Jan 4, 2018 |
PALVELLA THERAPEUTICS, INC.
|
10% Owner |
Sell |
15.0
|
-1,709,620
|
-23.55%
|
✗
|
$12.6M |
| Dec 18, 2017 |
Dec 20, 2017 |
PALVELLA THERAPEUTICS, INC.
|
10% Owner |
Sell |
20.0
|
-147,635
|
-1.99%
|
✗
|
$841.5K |
| Aug 31, 2017 |
Sep 5, 2017 |
GLAUKOS Corp
|
Director |
Sell |
15.0
|
-580,200
|
-9.62%
|
✗
|
$22.5M |
| Aug 15, 2017 |
Aug 17, 2017 |
GLAUKOS Corp
|
Director |
Sell |
15.0
|
-325,000
|
-6.38%
|
✗
|
$12.3M |
| Mar 10, 2017 |
Mar 14, 2017 |
GLAUKOS Corp
|
Director |
Sell |
15.0
|
-382,538
|
-4.91%
|
✗
|
$17.3M |
| Mar 3, 2017 |
Mar 7, 2017 |
GLAUKOS Corp
|
Director |
Sell |
17.5
|
-55,772
|
-2.56%
|
✗
|
$2.6M |
| Aug 10, 2016 |
Aug 12, 2016 |
GLAUKOS Corp
|
Director |
Sell |
16.3
|
-292,938
|
-4.17%
|
✗
|
$9.9M |
| Aug 3, 2016 |
Aug 5, 2016 |
GLAUKOS Corp
|
Director |
Sell |
15.0
|
-425,000
|
-14.67%
|
✗
|
$13M |
| Jun 27, 2016 |
Jun 29, 2016 |
Cartesian Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+550,000
|
42.54%
|
✗
|
$7.7M |
| Jun 27, 2016 |
Jun 29, 2016 |
Cartesian Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+550,000
|
42.54%
|
✗
|
$7.7M |
| Jul 6, 2015 |
Jul 8, 2015 |
PALVELLA THERAPEUTICS, INC.
|
Director |
Buy |
95.0
|
+500,000
|
7.40%
|
✗
|
$1.4M |
| Jun 30, 2015 |
Jun 30, 2015 |
GLAUKOS Corp
|
Director |
Sell |
40.0
|
-11,734
|
-0.40%
|
✗
|
$211.2K |
| Sep 4, 2012 |
Sep 5, 2012 |
AMARIN CORP PLC\UK
|
Director |
Sell |
5.0
|
-233,700
|
-28.03%
|
✓
|
$3.4M |
| Jul 27, 2012 |
Jul 30, 2012 |
AMARIN CORP PLC\UK
|
Director |
Sell |
3.8
|
-366,300
|
-30.53%
|
✓
|
$5.4M |
| Jun 19, 2012 |
Jun 19, 2012 |
AMARIN CORP PLC\UK
|
Director |
Sell |
16.3
|
-617,100
|
-33.96%
|
✗
|
$8M |